ORIGINAL RESEARCH article
Front. Neurol.
Sec. Endovascular and Interventional Neurology
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1668704
Mechanical Thrombectomy for Mild stroke with Anterior Circulation Large Vessel Occlusion: A Multicenter Cohort Study
Provisionally accepted
- 1Xianyang Hospital of Yan 'an University, Xianyang, China
- 2The First Hospital of Yulin and The Second Affiliated Hospital, Yanan University, Yulin, China
- 3Xi'an Medical University, Xi'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The clinical benefit of mechanical thrombectomy (MT) for anterior circulation emergency large vessel occlusion (ELVO) in patients presenting with a mild National Institutes of Health Stroke Scale score (<6) remains uncertain. We aimed to assess the efficacy and safety of MT in this patient population. Methods: We enrolled individuals presenting with mild stroke attributable to anterior circulation LVO from three stroke centers between March 2020 and June 2024. The primary endpoint was an excellent 90-day outcome, defined as a modified Rankin Scale (mRS) score of 0–1. Functional independence at day 90 (mRS 0–2) was considered the secondary endpoint. Safety endpoints consisted of symptomatic intracranial hemorrhage (sICH) and all-cause mortality within 90 days. Multivariable logistic regression with inverse probability of treatment weighting (IPTW) was applied to examine the association between MT and clinical outcomes. Results: In total, 140 individuals with mELVO were selected for analysis, receiving either MT (n = 48; 35 males; mean age: 59.9 years; NIHSS median: 4 [IQR 2–5]) or medical management (MM) (n = 92; 62 males; mean age: 61.9 years; NIHSS median: 3 [IQR 1–4]). No statistically significant differences were observed between the MT and MM groups in excellent outcome (aOR = 0.93; 95% CI, 0.41–2.11), functional independence (aOR =2.14; 95% CI, 0.77–5.91), symptomatic intracranial hemorrhage (aOR = 1.63; 95% CI, 0.37–7.14), or mortality (aOR = 0.56; 95% CI, 0.02–20.94). The results remained consistent after IPTW adjustment. Conclusion: Among patients with mELVO, MT was not associated with significantly different outcomes compared to MM. Further investigation through randomized controlled trials is warranted.
Keywords: ischemic stroke, Thrombectomy, Intracranial Hemorrhages, Mortality, Odds Ratio
Received: 18 Jul 2025; Accepted: 21 Aug 2025.
Copyright: © 2025 Zhang, Zhang, Li, Zhang, Li and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiongfei Zhao, Xianyang Hospital of Yan 'an University, Xianyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.